Up to $14M Awarded in Effort to Solve Key Challenges to Gene Delivery in Cystic Fibrosis
The Foundation remains committed to drawing the best scientific minds and technology into CF to deliver the next generation of transformative therapies for people with cystic fibrosis. As part of the Foundation’s $500 million Path to a Cure initiative, we announced funding of up to $14 million to 4D Molecular Therapeutics Inc. to develop a vehicle to deliver a healthy cystic fibrosis transmembrane conductance regulator (CFTR) gene into the lung cells of people with CF.
Read more »
| |
Vote for BreatheCon Artwork
| |
CFRD Research Webinar Recording Now Available
The recording from our cystic fibrosis-related diabetes (CFRD) research webinar is now available. Hear from CF research experts and members of the community about current and upcoming studies that aim to improve CFRD diagnosis and treatment, and how researchers are seeking community input on topics related to CFRD.
Watch the recording »
| |
My Experience with Telehealth
| |
|
|
|
|
